Scholar Rock Receives FDA's Priority Review Voucher For Isembyld
https://www.federalregister.gov/public-inspection/2026-21718/priority-review-voucher-rare-pediatric-disease-product-isembyld-apitegromab-mstn
Share
Why It Matters
Scholar Rock got a special fast-track badge from the FDA. This speeds up their medicine review and shows the government thinks it matters.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.